ARTICLES
-
-
Year
-
-
- Practices
-
Chinese Mainland Capital MarketsHong Kong & Overseas Capital MarketsInvestment/M&A & Corporate GovernanceCross-border Investment/M&AConstruction & Project DevelopmentFinancingDebt Restructuring & Non-performing AssetsTaxation & Wealth PlanningPrivate Equity & Investment FundsFinancial Products & TrustsLitigation & ArbitrationWhite Collar Crime & Criminal ComplianceBankruptcy-Insolvency & ReorganizationShippingCompliance & InvestigationAntitrust & CompetitionTrade Compliance & Trade RemediesCustoms & Import/ExportLabor & EmploymentHealth-Safety and Environmental ProtectionIP Licensing & EnforcementTrademark ProsecutionPatent ProsecutionCybersecurity & Data Protection
-
- Industries
-
Real EstateUrban InfrastructureTransportation & LogisticsTourism & HospitalityEnergy & PowerMining & Natural ResourcesBanking & Financial ServicesInsuranceFinancial Innovation & FintechTelecommunications & InternetInformation & Intelligence TechnologyHealthcarePharmaceuticals & Life SciencesEducation & TrainingMedia-Sports & EntertainmentNational Defense & Military IndustryRetail & Consumer ProductsIndustry & ManufacturingAgriculture & Food
-
- Latest
- Most relevant
-
-
2024-01-29
Law and Enforcement of China's Export Control and Sanction 2023
The article provides a review of the development and enforcement of China's export control and sanctions laws of 2023.
-
2024-01-25
New Chapter For Mainland-Hong Kong Judgements Enforcement
New arrangement of recognition and enforcement of judgements between Mainland and Hong Kong will take effect in Jan 2024
-
2024-01-24
Annual Review on International Trade Law in China (2023)
The article offers an annual review of the legislation and practices concerning China's international trade law in 2023.
-
2024-01-12
How Should Foreign Investors Adapt to China's New Company Law
This article discusses how foreign-invested enterprises should adapt to China's amended Company Law.
-
2024-01-11
China Released Second Catalogue of Rare Diseases
This article centres on the NMPA regulatory updates and overview for rare diseases and orphan drugs in China.